Hillhouse-backed Biotech Firm Jacobio Plans Up To $400m Hong Kong IPO

Business - Published date: Thursday August 06, 2020.

Jacobio Pharmaceuticals Co., a Chinese biotechnology company focusing on cancer treatments, is planning a Hong Kong ini... Read more